Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association
Gary Gintant, Paul Burridge, Lior Gepstein, Sian Harding, Todd Herron, Charles Hong, José Jalife, Joseph C. Wu
Fingerprint
Dive into the research topics of 'Use of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes in Preclinical Cancer Drug Cardiotoxicity Testing: A Scientific Statement From the American Heart Association'. Together they form a unique fingerprint.